Jäger T - Search Results

1

Angiogenic switch of angiopietins-Tie2 system and its prognostic value in bladder cancer.

Szarvas T, Jäger T, Tötsch M, vom Dorp F, Kempkensteffen C, Kovalszky I, Romics I, Ergün S, Rübben H. Szarvas T, et al. Among authors: jager t. Clin Cancer Res. 2008 Dec 15;14(24):8253-62. doi: 10.1158/1078-0432.CCR-08-0677. Clin Cancer Res. 2008. PMID: 19088043

2

Serum levels of angiogenic factors and their prognostic relevance in bladder cancer.

Szarvas T, Jäger T, Droste F, Becker M, Kovalszky I, Romics I, Ergün S, Rübben H. Szarvas T, et al. Among authors: jager t. Pathol Oncol Res. 2009 Jun;15(2):193-201. doi: 10.1007/s12253-008-9107-z. Epub 2008 Sep 20. Pathol Oncol Res. 2009. PMID: 18807212 Free article.

3

The prognostic value of cadherin switch in bladder cancer.

Jäger T, Becker M, Eisenhardt A, Tilki D, Tötsch M, Schmid KW, Romics I, Rübben H, Ergün S, Szarvas T. Jäger T, et al. Oncol Rep. 2010 Apr;23(4):1125-32. doi: 10.3892/or_00000741. Oncol Rep. 2010. PMID: 20204300

4

Urinary matrix metalloproteinase-7 level is associated with the presence of metastasis in bladder cancer.

Szarvas T, Singer BB, Becker M, Vom Dorp F, Jäger T, Szendroi A, Riesz P, Romics I, Rübben H, Ergün S. Szarvas T, et al. Among authors: jager t. BJU Int. 2011 Apr;107(7):1069-73. doi: 10.1111/j.1464-410X.2010.09625.x. Epub 2010 Sep 3. BJU Int. 2011. PMID: 20825402

5

Validation of circulating MMP-7 level as an independent prognostic marker of poor survival in urinary bladder cancer.

Szarvas T, Jäger T, Becker M, Tschirdewahn S, Niedworok C, Kovalszky I, Rübben H, Ergün S, vom Dorp F. Szarvas T, et al. Among authors: jager t. Pathol Oncol Res. 2011 Jun;17(2):325-32. doi: 10.1007/s12253-010-9320-4. Epub 2011 Jan 21. Pathol Oncol Res. 2011. PMID: 21253919 Free article.

6

Circulating angiostatin, bFGF, and Tie2/TEK levels and their prognostic impact in bladder cancer.

Szarvas T, Jäger T, Laszlo V, Kramer G, Klingler HC, vom Dorp F, Romics I, Ergün S, Rübben H. Szarvas T, et al. Among authors: jager t. Urology. 2012 Sep;80(3):737.e13-8. doi: 10.1016/j.urology.2012.03.023. Epub 2012 May 17. Urology. 2012. PMID: 22607948

7

[Use of silicon chip technology to detect protein-based tumor markers in bladder cancer].

Jäger T, Szarvas T, vom Dorp F, Börgermann C, Schenck M, Schmid KW, Rübben H. Jäger T, et al. Urologe A. 2007 Sep;46(9):1152-6. doi: 10.1007/s00120-007-1429-z. Urologe A. 2007. PMID: 17593336 German.

8

[From marker expression to individual therapy of patients with bladder cancer].

Vom Dorp F, Börgermann C, Jäger T, Becker M, Schmid KW, Rübben H. Vom Dorp F, et al. Among authors: jager t. Urologe A. 2008 Sep;47(9):1167-70. doi: 10.1007/s00120-008-1851-x. Urologe A. 2008. PMID: 18712513 Review. German.

9

[Plasma E-cadherin levels in urinary bladder cancer: does it improve risk stratification?].

Szarvas T, Hoffmann F, Becker M, Schenck M, Vom Dorp F, Rübben H, Jäger T. Szarvas T, et al. Among authors: jager t. Urologe A. 2011 Jan;50(1):64-70. doi: 10.1007/s00120-010-2454-x. Urologe A. 2011. PMID: 21153394 German.

10

[Siliconchiptechnology-based MMP-7 analysis in urine: an option for preoperative identification of lymph node metastasis in bladder cancer].

Jäger T, Tschirdewahn S, Vom Dorp F, Piechotta G, Rübben H, Szarvas T. Jäger T, et al. Urologe A. 2013 Jun;52(6):853-8. doi: 10.1007/s00120-012-3110-4. Urologe A. 2013. PMID: 23358831 Clinical Trial. German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

322 results

Search Page

Filters